| SS-Chr 12BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
0.56 |
g/mg |
0.07 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57385 |
522 |
| SS-Chr 12BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
8 |
1.08 |
g/mg |
0.11 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55849 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
8 |
0.06 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54735 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
-7.27 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56156 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
9 |
-7.52 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56164 |
522 |
| SS-Chr 12BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
83.0 |
% |
4.55 |
14.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54839 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
1.16 |
E-7mole |
0.16 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56571 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
-6.81 |
null |
0.06 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56974 |
522 |
| SS-Chr 12BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
10 |
1.01 |
g/mg |
0.13 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57393 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
8 |
-6.78 |
null |
0.1 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55686 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
8 |
1.95 |
E-7mole |
0.44 |
1.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55955 |
522 |
| SS-Chr 12BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
95.75 |
% |
3.71 |
10.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54831 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
9 |
0.03 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54965 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
1.72 |
E-7mole |
0.28 |
0.89 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56579 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
8 |
-7.25 |
null |
0.05 |
0.13 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55336 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
9 |
0.09 |
umol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54727 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
-6.96 |
null |
0.06 |
0.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56966 |
522 |
| SS-Chr 12BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
85.63 |
% |
4.46 |
12.63 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57277 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
-6.87 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55678 |
522 |
| SS-Chr 12BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
8 |
82.63 |
% |
4.65 |
13.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57285 |
522 |
| SS-Chr 12BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
9 |
-7.08 |
null |
0.06 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55328 |
522 |
| SS-Chr 12BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
0.76 |
g/mg |
0.14 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55841 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
1.46 |
E-7mole |
0.24 |
0.69 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55947 |
522 |
| SS-Chr 12BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
0.06 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54957 |
522 |